FDA

Federal health officials are investigating an E. coli outbreak tied to raw milk cheese that has sickened 13 people across the United States, according to the FDA. Eight of those infected required hospitalization. The announcement has renewed attention on the risks of unpasteurized dairy products and may prompt recalls or consumer warnings as the investigation continues.

Federal health agencies have connected an E. coli outbreak to a raw milk cheese brand, according to the CDC and FDA. The announcement has put a spotlight on the risks of unpasteurized dairy products, with news outlets including ABC News and KAKE reporting the link. Consumers are being urged to check whether products they have purchased are affected.

Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.

The FDA has announced a recall of raw milk cheese linked to an E. coli outbreak. The recall notice is being widely carried by local news outlets across the United States. Consumers who purchased the product are advised to check for affected batches, and health officials are warning about the risks of eating cheese made from unpasteurized milk during the ongoing outbreak investigation.

The FDA has announced a new nationwide recall of a blood pressure medication, prompting the agency to urge patients taking the affected product to check their supply and consult their doctor or pharmacist. Further details, including the manufacturer, specific lot numbers, and the reason for the recall, have not been reported.

Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.

A recall of a thyroid medication has been designated at the FDA's most serious risk level, known as Class I, reserved for situations where exposure could cause serious health problems or death. People with thyroid conditions are being advised to check their medication lots and contact their pharmacist or doctor if affected.

The FDA has released new guidance establishing a common playbook for companies developing surgical robots. The framework is expected to give robotic surgery manufacturers a clearer, more consistent path through regulatory review. Industry watchers say it could lower barriers for new entrants and speed approval of next-generation surgical robotics systems across the market.

Disc Medicine (IRON) is under scrutiny following an FDA setback and the disclosure of legal investigations, prompting investors to question whether the biotech stock is now undervalued. Coverage focuses on whether the share price already reflects the regulatory disappointment and litigation risks, or whether further downside remains for shareholders.